Back to search results

Cannabidiol for Bipolar Depression (CBD-BD)

Abroad (travel likely)RecruitingPHASE3

Conditions

Bipolar Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • UBC Mood Disorders Centre, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Shannon Reid, BA) · shannon.reid@ubc.ca · 604-822-8045
    Contact: Study coordinator (Nazlin Walji, BSc) · nazlin.walji@ubc.ca · 604-822-7294
    Contact: Principal Investigator (Lakshmi N Yatham, MBBS, MRCPsy)

  • St. Joseph's Healthcare, Hamilton, Ontario, Canada

    Contact: Principal Investigator (Gomes Fabiano, MD)

  • Providence Care Hospital, Kingston, Ontario, Canada

    Contact: Principal Investigator (Roumen Milev, MD)

  • Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

    Contact: Principal Investigator (Ayal Schaffer, MD)

  • Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada

    Contact: Principal Investigator (Arun Ravindran, MD)
    Nisha Ravindran, MD (Sub-investigator)

  • Douglas Mental Health University Institute, Montreal, Quebec, Canada

    Contact: Principal Investigator (Serge Beaulieu, MD)
Study leads

  • Lakshmi N Yatham, MBBS, MRCPsy

    Principal Investigator

    University of British Columbia, Department of Psychiatry

View source on ClinicalTrials.gov(opens in a new tab)